Gene · 187
Papers2,018
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,018
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Reciprocal Interactions Between Apelin and Noncoding RNAs in Cancer Progression. | Cell Biochem Funct | 2024 | 39233464 | PubTator, text mining | PubMed |
| Unraveling the Complex Molecular Interplay and Vascular Adaptive Changes in Hypertension-Induced Kidney Disease. | Biomedicines | 2024 | 39200188 | PubTator, text mining | PubMed |
| Apelin - A New Kid on the Block in Periodontology. | Oral Health Prev Dent | 2024 | 39189510 | PubTator, text mining | PubMed |
| Molecular docking with conformer-dependent charges. | Phys Chem Chem Phys | 2024 | 39158190 | PubTator, text mining | PubMed |
| Apelin modulates inflammation and leukocyte recruitment in experimental autoimmune encephalomyelitis. | Nat Commun | 2024 | 39060233 | PubTator, text mining | PubMed |
| Hyperandrogenemia elevates expression of apelin and apelin receptor protein in the mice pituitary. | J Exp Zool A Ecol Integr Physiol | 2024 | 38973535 | PubTator, text mining | PubMed |
| Neural progenitor-derived Apelin controls tip cell behavior and vascular patterning. | Sci Adv | 2024 | 38968355 | PubTator, text mining | PubMed |
| Hormonal dependent expression of apelin and apelin receptor in the ovary and uterus of mice. | Reprod Biol | 2024 | 38924877 | PubTator, text mining | PubMed |
| Neuroprotective Effect and Mechanism of Tanreqing Injection on Ischemic Stroke: Insights from Network Pharmacology and in vivo Experiments. | Chin J Integr Med | 2024 | 38910191 | PubTator, text mining | PubMed |
| The extract of an herbal medicine Chebulae fructus inhibits hepatocellular carcinoma by suppressing the Apelin/APJ system. | Front Pharmacol | 2024 | 38881868 | PubTator, text mining | PubMed |
| Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial. | J Immunother Cancer | 2024 | 38862251 | PubTator, text mining | PubMed |
| Molecular Changes Implicate Angiogenesis and Arterial Remodeling in Systemic Sclerosis-Associated and Idiopathic Pulmonary Hypertension. | Arterioscler Thromb Vasc Biol | 2024 | 38841857 | PubTator, text mining | PubMed |
| Expression of the apelin receptor, a novel potential therapeutic target, and its endogenous ligands in diverse stem cell populations in human glioblastoma. | Front Neurosci | 2024 | 38803685 | PubTator, text mining | PubMed |
| Editorial: Developmental biology and endocrine research for a successful pregnancy. | Front Endocrinol (Lausanne) | 2024 | 38803471 | PubTator, text mining | PubMed |
| Apelin receptor dimer: Classification, future prospects, and pathophysiological perspectives. | Biochim Biophys Acta Mol Basis Dis | 2024 | 38795836 | PubTator, text mining | PubMed |
| Decreased plasma ELABELA level as a novel screening indicator for heart failure: a cohort and observational study. | Sci Rep | 2024 | 38760403 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Analyses Identify APLNR, INS-IGF2, RGCC Genes May Be Involved in the Pathogenesis of Systemic Sclerosis Skin. | Clin Cosmet Investig Dermatol | 2024 | 38742168 | PubTator, text mining | PubMed |
| Apelin receptor modulation mitigates letrozole-induced polycystic ovarian pathogenesis in mice. | Cytokine | 2024 | 38733946 | PubTator, text mining | PubMed |
| ELABELA-APJ Axis Enhances Mesenchymal Stem Cell Proliferation and Migration via the METTL3/PI3K/AKT Pathway. | Acta Naturae | 2024 | 38698964 | PubTator, text mining | PubMed |
| Integration of the Butina algorithm and ensemble learning strategies for the advancement of a pharmacophore ligand-based model: an in silico investigation of apelin agonists. | Front Chem | 2024 | 38690013 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/187/papers?page=8